Fetal and Maternal Outcomes of Planned Pregnancy in Patients with Systemic Lupus Erythematosus: A Retrospective Multicenter Study

Journal of Immunology Research
Dongying ChenZhongping Zhan


To investigate the fetal and maternal outcomes as well as predictors of APOs in women with SLE who conceived when the disease was stable, the so-called "planned pregnancy." Methods. A retrospective multicenter study of 243 patients with SLE who underwent a planned pregnancy was performed. APOs in fetus and mothers were recorded. The average age at conception was 28.9 ± 3.9 years. Duration of SLE prior to pregnancy was 4.4 ± 4.3 years. Fetal APOs occurred in 86 (86/243, 35.4%) patients. Preterm births, intrauterine growth retardation (IUGR), fetal distress, and fetal loss accounted for 22.2%, 14.8%, 11.1%, and 4.9%, respectively. Forty-two preterm infants (42/54, 77.8%) were delivered after the 34th week of gestation. All the preterm infants were viable. Fifty-two patients (52/243, 21.4%) had disease flares, among which 45 cases (45/52, 86.5%) were mild, 6 (6/52, 11.5%) were moderate, and 1 (1/52, 1.9%) was severe. Disease flares were mainly presented as active lupus nephritis (41/52, 78.8%), thrombocytopenia (10/52, 19.2%), and skin/mucosa lesions (9/52, 17.3%). Pregnancy-induced hypertension (PIH) occurred in 29 patients, among which 3 were gestational hypertension and 26 were preeclampsia. Multiple analysis showed that diseas...Continue Reading


Feb 5, 2005·Arthritis and Rheumatism·Megan E B ClowseMichelle Petri
May 6, 2008·American Journal of Obstetrics and Gynecology·Megan E B ClowseAndra H James
Aug 7, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Andrew SmythVesna D Garovic
Nov 26, 2010·Seminars in Perinatology·Lavone E SimmonsMichael G Gravett
Dec 15, 2010·Lupus·N RupertoUNKNOWN Lupus Foundation of America, Inc. International Flare Consensus Initiative
Jan 31, 2013·Annals of the Rheumatic Diseases·Megan E B ClowseDavid S Pisetsky
Jan 31, 2014·Current Atherosclerosis Reports·Amanda R Vest, Leslie S Cho
Jun 23, 2015·Annals of Internal Medicine·Jill P BuyonJane E Salmon
Oct 26, 2016·Journal of Autoimmunity·Gabriella MoroniMarta Mosca
Aug 25, 2016·Integrated Blood Pressure Control·Rosemary TownsendAsma Khalil
Oct 1, 2016·Annual Review of Medicine·Lisa R Sammaritano

❮ Previous
Next ❯


Mar 7, 2019·Der Internist·J SchreiberK de Groot
Sep 21, 2019·PloS One·Syahrul Sazliyana ShaharirRahana Abdul Rahman
Apr 1, 2020·International Journal of Rheumatic Diseases·Miguel Ángel SaavedraLuis Javier Jara
Jul 28, 2020·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·R Douglas Wilson
Apr 26, 2021·Reumatología clinica·Cintia OtaduyPaula Alba Moreyra

❮ Previous
Next ❯

Methods Mentioned


Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.